Concerns about the ethics of evidence-based medicine (EBM) relate to possib
le alterations in the humane basis of clinical care.
In collecting the evidence for EBM, scientists and doctors, not consumers,
determine research objectives, interpret the data and implement the finding
s, and in doing so may disregard patients' priorities.
Ethical standards, and what counts as evidence, are determined by socially
or commercially powerful groups connected to powerful institutions. Such gr
oups can generate evidence and determine "gold tandard" knowledge, filterin
g out other, "inferior" knowledge.
Applying the available evidence to predicting outcomes for individual patie
nts involves uncertainty. Full disclosure of this uncertainty is a componen
t of informed consent, but requires sensitivity to patients' tolerance of a
mbiguity.
Ongoing debate about the ethics of EBM on all levels will ensure that EBM m
anifests intended and preferred social values and takes its rightful place
in the practice of medicine and the development of health policy.